Home › Funds › Boxer Capital Management, LLC › PGEN

Boxer Capital Management, LLC position in PGEN

PRECIGEN INC · Health Care

Boxer Capital Management, LLC reported holding 5,150,000 shares of PGEN (PRECIGEN INC) in its Q2 2026 13F filing — a position valued at US$29.4M, representing 2.21% of its reported portfolio and ranking #12 among its reported holdings. Boxer Capital Management, LLC has disclosed PGEN holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)5.15M sh
Reported value held$29.36M
Portfolio Weight2.21%
First reportedQ3 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Boxer Capital Management, LLC's PGEN position evolved

Boxer Capital Management, LLC first disclosed a stake in PGEN in Q3 2025 at 850,000 shares (US$2.8M). The position peaked in Q2 2026 at 5,150,000 shares, worth US$29.4M. Across 4 filings, Boxer Capital Management, LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 5,150,000 shares valued at US$29.4M — an increase of 1,650,000 shares quarter over quarter.. Notable position changes include a 62% increase in Q4 2025 (shares fell 7% over the following quarter), a 155% increase in Q1 2026 (shares rose 47% over the following quarter), a 47% increase in Q2 2026 (shares rose 50% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 850.00K $2.80M New
Q4 2025 1.38M $5.75M Add
Q1 2026 3.50M $13.54M Add
Q2 2026 5.15M $29.36M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PGEN and 13F data

PGEN (PRECIGEN INC) is a Health Care company. 58 other funds we track also report a position in PGEN — the largest reported positions include Patient Capital Management, LLC (US$108.5M), TANG CAPITAL MANAGEMENT LLC (US$36.6M), IRIDIAN ASSET MANAGEMENT LLC/CT (US$23.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PGEN

All PGEN fund holders →

FAQ

How long has Boxer Capital Management, LLC held PGEN?

Boxer Capital Management, LLC has disclosed PGEN holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Boxer Capital Management, LLC's current position in PGEN?

As of Q2 2026, Boxer Capital Management, LLC holds 5.15M shares of PGEN (PRECIGEN INC), valued at $29.36M, representing 2.21% of its reported portfolio and ranking #12.

Has Boxer Capital Management, LLC been buying or selling PGEN?

In the latest 13F filing (Q2 2026), Boxer Capital Management, LLC increased its position in PGEN. The position peaked in Q2 2026 at 5.15M shares.

Which other funds hold PGEN?

Other major institutional holders of PGEN include Patient Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, IRIDIAN ASSET MANAGEMENT LLC/CT, among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.